December/January 2007

In this issue

2006 was an active, productive, exciting year

Welcome new medical staff members

Glanzmann’s thrombasthenia – a rare congenital platelet function defect

New Texas Children’s Fetal Center advancements exemplify Vision 2010 model of ‘excellence to eminence’

Texas Children's News for the medical staff

Grand Rounds

Medical staff committees and chairs

Home

Archives


Advisors

Ralph D. Feigin, M.D.
Physician-in-Chief
Texas Children's Hospital
Professor and Chairman
Department of Pediatrics
Baylor College of Medicine

Joseph A. Garcia-Prats, M.D.
Neonatologist
Texas Children's Hospital
Professor of Pediatrics and Professor of Medical Ethics Baylor College of Medicine

Arnold G. Kagan, M.D.
Clinical Associate Professor of Pediatrics

Editor
Cindy Shanley
Marketing and Public Relations
Texas Children’s Hospital
832-824-2180
 

Diagnostic Virology
Laboratory Newsletter

 

 
 


For  members of the Texas Children's Hospital medical staff

New Texas Children’s Fetal Center advancements
exemplify Vision 2010 model of ‘Excellence to Eminence’


By Dale Brown Jr., M.D.

To continue in Texas Children’s mission for saving lives and enhancing fetal outcomes is the impetus for the establishment of the new Texas Children’s Fetal Center.

 

As Texas Children’s Hospital moves to new initiatives encompassing maternal care with the technology of the future, many babies who may have died or would have sustained life-threatening handicaps may now have the opportunity to overcome these obstacles. Having the knowledge that good maternal care results in healthy babies has led to plans for building a maternity center at Texas Children’s Hospital.

 

Focusing on high-risk pregnancies and attempting to lessen their morbidity resulted in the recruitment of two outstanding fetal interventionists from the University of North Carolina – Anthony Johnson, D.O., and Kenneth J. Moise Jr., M.D.– to the Department of Obstetrics and Gynecology at Baylor College of Medicine. These physicians will be the cornerstones for the maternal-fetal portion of fetal intervention.

Filling the geographic gap in fetal intervention and surgery care
Conditions such as twin-to-twin transfusion that occur in identical twins between 10 and 15 percent and usually result in a greater than 90 percent mortality now allow twins to survive, reversing the statistics up to a 90 percent survival rate. Treatment for the twin-to-twin transfusion consists of lasering and coagulation of abnormal fetal vessels in utero usually between the fourth and fifth months of pregnancy. Intubation and insertion of balloons into the lungs to prevent advancement of pulmonary hypoplasia in those babies with severe diaphragmatic hernias now gives those infants a chance for survival, where previously there had been none. Angioplasty in utero in infants with severe aortic arch stenosis will enable babies to be born alive and subsequently undergo necessary appropriate cardiac surgery by the fetal surgeons. Future technology will allow possibility of stem cell transplant.

 

All of these procedures are done while the baby is in the amniotic sac in the uterus. These are just a few of the potential treatments that will be available in the Texas Children’s Fetal Center, which will make Texas Children’s Hospital a national and international leader of fetal intervention and pediatric surgery. The only fetal intervention center that exists today in the south is in Florida; none exist in the Midwest or southeast regions of the country. Before now, fetal intervention centers existed only on the East and West Coasts. Patients’ mothers who previously had babies affected with significant abnormalities necessitated referral to centers in these venues for appropriate treatment. This will no longer be the case. They will be cared for by the Texas Children’s Fetal Center. One can easily foresee this will entice and enable recruitment for some of the best academic physicians in the future.

 

This is the first step in the development over the ensuing years of the future Texas Children’s maternity center. Academic research with appropriate outcomes determining care of patients will become a milestone for institutions throughout the country. Translational research will deal with hypertension in pregnancy, diabetes in pregnancy, cardiovascular disease hemoglobinopathies, and other severe morbid conditions.

Advancing in leaps and bounds
When considering the potential for fetal intervention, one has to imagine a “Star Wars” approach in that there are innumerable opportunities in the future as technology advances. For example, with the advancement of mini robotic instrumentation fetal surgeons will be able to perform intricate fetal surgery in utero.

 

Medicine is reaching a level in which technology is becoming so advanced that if you can imagine something that you would like to have done, with time it will be possible to accomplish. Genetic therapy with the potential of absolution of certain diseases exists. Collaboration with the genetics department at Baylor will further the horizon for improvement of medical care. This is why so much excitement exists with the fetal intervention and pediatric surgery program, which is moving ahead in leaps and bounds. Those who are involved with development and realization of such life-saving and life-changing procedures truly exemplify the Vision 2010 model of “Excellence to Eminence.”

Dale Brown Jr., M.D., is acting chief of Obstetrics and Gynecology at Texas Children’s Hospital and  interim chairman and professor of Obstetrics and Gynecology at Baylor College of Medicine.

 

Back to top

 

 

  Home     |     Contact us         Terms of use       Visit Texas Children's Hospital Web site    |    © 2006 Texas Children’s Hospital